Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/18374
Title: Chemoimmunotherapy May Not Be Dead Yet in Chronic Lymphocytic Leukemia, But Fludarabine Plus Cyclophosphamide Plus Rituximab Is Potentially Facing Life Support.
Austin Authors: Opat, Stephen;Hawkes, Eliza A 
Affiliation: Austin Health, Heidelberg, Victoria, Australia
Monash University, Melbourne, Australia
Monash Health, Clayton, Australia
Eastern Health, Box Hill, Australia
Issue Date: 20-Dec-2017
metadata.dc.date: 2017-11-03
Publication information: Journal of Clinical Oncology 2017; 35(36): 4093-4094
URI: http://ahro.austin.org.au/austinjspui/handle/1/18374
DOI: 10.1200/JCO.2017.75.4721
PubMed URL: 29099632
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

6
checked on Dec 2, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.